Latest Headlines

  1. MDARD's Plant Pathology Laboratory Achieves Nation's First Core Accreditation From The National Plant Diagnostic Network 10/28/2024

    The Michigan Department of Agriculture and Rural Development (MDARD) Director Tim Boring today heralded a monumental achievement as the department’s Plant Pathology Laboratory became the nation’s first to be granted accreditation status under the National Plant Diagnostic Network (NPDN) Core Accreditation Program.

  2. FluidAI Collaborates With Mayo Clinic Platform To Develop AI-Driven Postoperative Monitoring Solutions 10/28/2024

    FluidAI Medical (FluidAI), a leader in artificial intelligence (AI)-driven postoperative monitoring, announced a collaboration to access de-identified clinical data through Mayo Clinic Platform_Discover.

  3. New Multi-Marker Blood Test From Lucent Diagnostics Increases The Number Of Patients Receiving Early Alzheimer's Disease Diagnostic Information 10/25/2024

    Lucent Diagnostics, a brand of Quanterix Corporation, has introduced LucentAD Complete, a new multi-marker blood test designed to help detect Alzheimer’s Disease (AD) in a broader range of patients.

  4. LabGenomics USA Completes Acquisition Of IMD CLIA Labs 10/25/2024

    LabGenomics USA has successfully acquired Integrated Molecular Diagnostics (IMD) CLIA labs, bringing the total number of its CLIA-certified labs in the U.S. to four. This acquisition strengthens LabGenomics’ strategic development and expands its diagnostic services nationwide, particularly in molecular technology.

  5. Introducing Testing Assistant ALEX: The New Compact Automation Solution For Small Test Series 10/24/2024

    This week, at testXpo 32nd International Expo for Materials Testing, ZwickRoell introduced ALEX, the newest addition to their industry-leading automated testing portfolio.

  6. Pillar Biosciences Receives CPT® Code For FDA Approved oncoReveal™ CDx Pan-Cancer Solid Tumor IVD Kit 10/24/2024

    Pillar Biosciences, Inc., the leader in Decision Medicine™, today announced that they have been granted a unique CPT® Proprietary Laboratory Analyses (PLA) code 0523U from the American Medical Association (AMA) for their FDA approved oncoReveal™ CDx pan-cancer solid tumor in vitro diagnostic (IVD) NGS kit.

  7. Researchers Flip Genes On And Off With AI-Designed DNA Switches 10/23/2024

    Researchers at The Jackson Laboratory (JAX), the Broad Institute of MIT and Harvard, and Yale University, have used artificial intelligence to design thousands of new DNA switches that can precisely control the expression of a gene in different cell types.

  8. hc1 Acquires Lab Expert Accumen Tto Expand Data-Driven Lab Insights 10/22/2024

    hc1, the healthcare information technology leader in improving patient care and reducing costs through real-time lab data insights, today announced it has acquired Accumen, a best-in-class healthcare performance consulting company based in Scottsdale, Arizona.

  9. Artera Receives California Lab License, Expanding Access To Its ArteraAI Prostate Test 10/22/2024

    Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer tests, announced today it has received its California laboratory license from the California Department of Public Health (CDPH).

  10. Quest Diagnostics Awarded CDC Contracts For H5 Avian Influenza And Oropouche Virus Test Development 10/22/2024

    Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced that it has been awarded several contracts by the U.S. Centers for Disease Control and Prevention (CDC) to support testing and sustained laboratory readiness for two emerging infectious diseases recently identified in people in the Americas.